Romano Carmela, Morena Emanuele, Petrucci Simona, Diamant Selene, Marconi Martina, Travaglini Lorena, Zanni Ginevra, Piane Maria, Salvetti Marco, Romano Silvia, Ristori Giovanni
Department of Human Neurosciences, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Front Neurol. 2024 Mar 20;15:1362013. doi: 10.3389/fneur.2024.1362013. eCollection 2024.
Alexander disease (AxD) is a rare inherited autosomal dominant (AD) disease with different clinical phenotypes according to the age of onset. It is caused by mutations in the glial fibrillary acid protein (GFAP) gene, which causes GFAP accumulation in astrocytes. A wide spectrum of mutations has been described. For some variants, genotype-phenotype correlations have been described, although variable expressivity has also been reported in late-onset cases among members of the same family. We present the case of a 19-year-old girl who developed gait ataxia and subtle involuntary movements, preceded by a history of enuresis and severe scoliosis. Her mother has been affected by ataxia since her childhood, which was then complicated by pyramidal signs and heavily worsened through the years. Beyond her mother, no other known relatives suffered from neurologic syndromes. The scenario was further complicated by a complex brain and spinal cord magnetic resonance imaging (MRI) pattern in both mother and daughter. However, the similar clinical phenotype made an inherited cause highly probable. Both AD and autosomal recessive (AR) ataxic syndromes were considered, lacking a part of the proband's pedigree, but no causative genetic alterations were found. Considering the strong suspicion for an inherited condition, we performed clinical exome sequencing (CES), which analyzes more than 4,500 genes associated with diseases. CES evidenced the new heterozygous missense variant c.260 T > A in exon 1 of the glial fibrillary acidic protein (GFAP) gene (NM_002055.4), which causes the valine to aspartate amino acid substitution at codon 87 (p. Val87Asp) in the GFAP. The same heterozygous variant was detected in her mother. This mutation has never been described before in the literature. This case should raise awareness for this rare and under-recognized disease in juvenile-adult cases.
亚历山大病(AxD)是一种罕见的常染色体显性(AD)遗传病,根据发病年龄具有不同的临床表型。它由胶质纤维酸性蛋白(GFAP)基因突变引起,该突变导致GFAP在星形胶质细胞中蓄积。已描述了广泛的突变谱。对于某些变异体,已描述了基因型-表型相关性,尽管在同一家族的晚发病例中也报道了可变表达。我们报告了一名19岁女孩的病例,她出现步态共济失调和轻微不自主运动,之前有尿床和严重脊柱侧弯病史。她的母亲自童年起就患有共济失调,随后出现锥体束征并逐年严重恶化。除了她的母亲,没有其他已知亲属患有神经综合征。母女俩复杂的脑和脊髓磁共振成像(MRI)表现使情况更加复杂。然而,相似的临床表型使遗传病因极有可能。考虑了常染色体显性和常染色体隐性(AR)共济失调综合征,但由于先证者家系部分缺失,未发现致病基因改变。鉴于强烈怀疑为遗传性疾病,我们进行了临床外显子组测序(CES),该方法可分析4500多个与疾病相关的基因。CES证实了胶质纤维酸性蛋白(GFAP)基因(NM_002055.4)外显子1中存在新的杂合错义变异c.260 T > A,该变异导致GFAP中第87位密码子的缬氨酸被天冬氨酸替代(p.Val87Asp)。在她母亲身上也检测到了相同的杂合变异。该突变在文献中从未被描述过。该病例应提高对这种在青少年-成人病例中罕见且认识不足的疾病的认识。